Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Jun:41 Suppl 1:89-94.
doi: 10.1111/liv.14869.

Current management of NAFLD/NASH

Ana Carolina Cardoso  1 , Claudio de Figueiredo-Mendes  2 , Cristiane A Villela-Nogueira  1
Affiliations

Current management of NAFLD/NASH

Ana Carolina Cardoso et al. Liver Int. 2021 Jun.

Abstract

NAFLD is the most common cause of liver disease worldwide, and its prevalence is significantly increasing. Studies have shown that it is associated with comorbidities such as diabetes, metabolic syndrome and obesity. Early diagnosis and management are highly important and could modify the prognosis of the disease. Evaluating the possibility of multiple aetiologies and recognizing the additional causes of liver disease should be a part of the patient's initial assessment. There are no approved drug treatments as yet, so the main management strategies should involve lifestyle changes such as physical activity and dietary re-education.

Keywords: NAFLD; NASH; diet; lifestyle; physical activity.

PubMed Disclaimer

References

REFERENCES

    1. Masarone M, Federico A, Abenavoli L, Loguercio C, Pérsico M. Nonalcoholic fatty liver: epidemiology and natural history. Rev Recent Clin Trials. 2014;9(3):126-133.
    1. Targher G, Bertolini L, Padovani R, et al. prevalence of non-alcoholic fatty liver disease and its association with cardiovascular disease among type 2 diabetic patients. Diabetes Care. 2007;30(5):1212-1218.
    1. Mummadi RR, Kasturi KS, Chennareddygari S, Sood GK. Effect of bariatric surgery on non-alcoholic fatty liver disease: systematic review and meta-analysis. Clin Gastroenterol Hepatol. 2008;6:1396-1402.
    1. Degenhardt L, Charlson F, Ferrari A, et al. The global burden of disease attributable to alcohol and drug use in 195 countries and territories, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet Psychiatry. 2018;5(12):987-1012.
    1. Eslam M, Newsome PN, Sarin SK, et al. A new definition for metabolic dysfunction-associated fatty liver disease: An international expert consensus statement. J Hepatol. 2020;73(1):202-209.

MeSH terms

LinkOut - more resources